Annual CFO:
-$36.98M+$10.04M(+21.36%)Summary
- As of today, XERS annual cash from operations is -$36.98 million, with the most recent change of +$10.04 million (+21.36%) on December 31, 2024.
- During the last 3 years, XERS annual cash from operations has risen by +$58.55 million (+61.29%).
- XERS annual cash from operations is now -129.88% below its all-time high of -$16.09 million, reached on December 31, 2016.
Performance
XERS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$182.00K+$10.21M(+101.81%)Summary
- As of today, XERS quarterly cash from operations is $182.00 thousand, with the most recent change of +$10.21 million (+101.81%) on June 30, 2025.
- Over the past year, XERS quarterly cash from operations has increased by +$10.53 million (+101.76%).
- XERS quarterly cash from operations is now -97.56% below its all-time high of $7.47 million, reached on December 31, 2023.
Performance
XERS Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$16.18M+$10.53M(+39.42%)Summary
- As of today, XERS TTM cash from operations is -$16.18 million, with the most recent change of +$10.53 million (+39.42%) on June 30, 2025.
- Over the past year, XERS TTM cash from operations has increased by +$21.61 million (+57.19%).
- XERS TTM cash from operations is now -359.76% below its all-time high of -$3.52 million, reached on March 31, 2017.
Performance
XERS TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
XERS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +21.4% | +101.8% | +57.2% |
| 3Y3 Years | +61.3% | +100.9% | +86.6% |
| 5Y5 Years | +64.6% | +100.8% | +83.7% |
XERS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +64.1% | -97.6% | +100.7% | at high | +86.0% |
| 5Y | 5-Year | at high | +64.6% | -97.6% | +100.4% | at high | +86.6% |
| All-Time | All-Time | -129.9% | +64.6% | -97.6% | +100.4% | -359.8% | +86.6% |
XERS Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $182.00K(+101.8%) | -$16.18M(+39.4%) |
| Mar 2025 | - | -$10.03M(-607.9%) | -$26.71M(+27.8%) |
| Dec 2024 | -$36.98M(+21.4%) | $1.98M(+123.8%) | -$36.98M(-17.5%) |
| Sep 2024 | - | -$8.30M(+19.7%) | -$31.48M(+16.7%) |
| Jun 2024 | - | -$10.35M(+49.0%) | -$37.79M(+8.2%) |
| Mar 2024 | - | -$20.30M(-371.8%) | -$41.19M(+12.4%) |
| Dec 2023 | -$47.02M(+54.3%) | $7.47M(+151.1%) | -$47.02M(+33.4%) |
| Sep 2023 | - | -$14.61M(-6.3%) | -$70.61M(+4.3%) |
| Jun 2023 | - | -$13.74M(+47.4%) | -$73.76M(+8.5%) |
| Mar 2023 | - | -$26.14M(-62.2%) | -$80.62M(+21.6%) |
| Dec 2022 | -$102.89M(-7.7%) | -$16.12M(+9.2%) | -$102.89M(+11.1%) |
| Sep 2022 | - | -$17.75M(+13.9%) | -$115.72M(+4.0%) |
| Jun 2022 | - | -$20.61M(+57.4%) | -$120.58M(-0.5%) |
| Mar 2022 | - | -$48.41M(-67.2%) | -$119.99M(-25.6%) |
| Dec 2021 | -$95.53M | -$28.95M(-28.0%) | -$95.53M(-23.3%) |
| Sep 2021 | - | -$22.61M(-12.9%) | -$77.46M(-7.8%) |
| Jun 2021 | - | -$20.02M(+16.4%) | -$71.83M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$23.96M(-120.4%) | -$75.57M(+6.2%) |
| Dec 2020 | -$80.56M(+22.8%) | -$10.87M(+36.0%) | -$80.56M(+18.8%) |
| Sep 2020 | - | -$16.98M(+28.5%) | -$99.26M(+12.0%) |
| Jun 2020 | - | -$23.76M(+17.9%) | -$112.86M(-0.6%) |
| Mar 2020 | - | -$28.95M(+2.1%) | -$112.14M(-7.5%) |
| Dec 2019 | -$104.35M(-85.4%) | -$29.57M(+3.3%) | -$104.35M(-12.1%) |
| Sep 2019 | - | -$30.58M(-32.8%) | -$93.11M(-18.7%) |
| Jun 2019 | - | -$23.04M(-8.9%) | -$78.44M(-12.7%) |
| Mar 2019 | - | -$21.15M(-15.4%) | -$69.63M(-23.7%) |
| Dec 2018 | -$56.28M(-128.2%) | -$18.34M(-15.2%) | -$56.28M(-19.6%) |
| Sep 2018 | - | -$15.92M(-11.9%) | -$47.04M(-28.2%) |
| Jun 2018 | - | -$14.22M(-82.2%) | -$36.70M(-63.3%) |
| Mar 2018 | - | -$7.80M(+14.2%) | -$22.48M(-23.6%) |
| Dec 2017 | -$24.66M(-53.3%) | -$9.10M(-63.2%) | -$18.20M(-100.0%) |
| Sep 2017 | - | -$5.58M(-58.5%) | -$9.10M(-158.5%) |
| Mar 2017 | - | -$3.52M | -$3.52M |
| Dec 2016 | -$16.09M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual cash from operations year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly cash from operations year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM cash from operations year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual cash from operations?
The current annual cash from operations of XERS is -$36.98M
What is the all-time high annual cash from operations for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual cash from operations is -$16.09M
What is Xeris Biopharma Holdings, Inc. annual cash from operations year-on-year change?
Over the past year, XERS annual cash from operations has changed by +$10.04M (+21.36%)
What is Xeris Biopharma Holdings, Inc. quarterly cash from operations?
The current quarterly cash from operations of XERS is $182.00K
What is the all-time high quarterly cash from operations for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly cash from operations is $7.47M
What is Xeris Biopharma Holdings, Inc. quarterly cash from operations year-on-year change?
Over the past year, XERS quarterly cash from operations has changed by +$10.53M (+101.76%)
What is Xeris Biopharma Holdings, Inc. TTM cash from operations?
The current TTM cash from operations of XERS is -$16.18M
What is the all-time high TTM cash from operations for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM cash from operations is -$3.52M
What is Xeris Biopharma Holdings, Inc. TTM cash from operations year-on-year change?
Over the past year, XERS TTM cash from operations has changed by +$21.61M (+57.19%)